Delivery Order SPE2DB24D2216-SPE2DB25FGPMC
Award Date 8/8/25
Potential Completion Date 8/11/25
Potential Value $6.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,465.80 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 11, 2025, with an ultimate completion date of December 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military...
- The Defense Logistics Agency awarded a delivery order valued at $6,840.95 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on November 24, 2025, with completion targeted for November 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,101.17 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical delivery under the company's broader federal contracting relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $41,754.56 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on September 15, 2025, with a completion date of September 16, 2025. This firm fixed-price, competitively awarded delivery order was issued under a non-set-aside procurement and represents a single line-item pharmaceutical supply to support federal medical needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a delivery order valued at $45,395.82 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-unit package) on September 24, 2025, with completion scheduled for September 25, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing for pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) valued at $6,660.55 under a firm fixed-price contract with a completion date of January 5, 2026. This award represents a non-set-aside, competitively awarded delivery order supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the...
- The Defense Logistics Agency awarded a delivery order valued at $17,363.67 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on August 25, 2025, with completion expected by August 26, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's medical supply chain and...
- The Defense Logistics Agency awarded a delivery order valued at $9,702.86 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on September 12, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $10,186.03 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30 count) on October 27, 2025, with completion expected by October 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents pharmaceutical procurement to support federal medical supply needs. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a Delivery Order valued at $24,066.84 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...